Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference


Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will participate in Craig-Hallum’s 18th Annual Institutional Investor Conference on Wednesday, June 2, 2021.

Each year, Craig-Hallum hosts a multi-industry investor conference in Minneapolis featuring over 150 public companies where institutional clients can meet formally with corporate management. This year’s conference will be virtual and consists of one-on-one conference calls of 30-minutes’ duration. Attendance is by invitation only. For more information about the conference or to inquire about scheduling a one-on-one meeting with Mr. O’Connor, please contact Hayden IR at [email protected].

About Simulations Plus, Inc.

Serving clients worldwide for 25 years, Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | Read our Environmental, Social, and Governance (ESG) Report.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005320/en/

Simulations Plus Aktie

34,00 €
4,29 %
Simulations Plus kann heute starke Zuwächse vorweisen. Die Aktie notiert im Vergleich zu gestern um 4,29 % höher.
Die Community bevorzugt leicht Simulations Plus, mit etwas mehr Buy- (3) als Sell-Einschätzungen (0).
Eine deutliche Steigerung um mehr als 20% ist für Simulations Plus mit einem Kursziel von 51 € gegenüber 34.0 € zu erwarten.
Like: 0
Teilen
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Rechtlicher Hinweis

Kommentare